XS Innovations

XS Innovations is a medical‑device startup (spin‑out of Leiden University Medical Center & Delft University of Technology) that develops an implantable vascular access solution for patients undergoing hemodialysis: the “Dynamic AVF”.

Their device works by opening the artery‑vein connection only during dialysis sessions — avoiding the constantly high and turbulent blood flow typical for traditional arteriovenous fistulas. By doing so, they aim to drastically reduce complications associated with vascular access (such as aneurysms, heart stress, access failure), improving safety and quality of life for patients with end‑stage kidney disease. 

Our news

March 6, 2026

819 Capital Partners acquires key assets of Lead Pharma, enabling continuation of operations

Deventer, 6 March 2026 - 819 Capital Partners has acquired the key assets of Lead Pharma, thereby realizing a continuation based on the company’s patent portfolio and associated research programs. The transaction includes intellectual property rights, research data, and selected development programs. Lead Pharma develops innovative small-molecule medicines for the treatment of cancer and autoimmune diseases. Over the past years, the company built a strong research platform and multiple drug candidates, collaborating with international pharmaceutical companies...

Continue reading
February 10, 2026

819 Capital Partners acquires Chalet.nl

Deventer, 10 February 2026 – 819 Capital Partners announces the acquisition of Chalet.nl, a well-established Dutch touroperator that has been a leading authority in winter sports holidays for more than 25 years. Chalet.nl specializes in the organization and rental of chalets and apartments in leading winter sports destinations across France, Austria, Switzerland and Italy. The company has built a strong online presence and is known for its reliable service, personal approach, and deep expertise in...

Continue reading